ImmunoPrecise Antibodies Ltd. ("IPA" or the "Company") , a leader in AI-driven antibody discovery and development, today announced the successful completion of its previously disclosed USD $8.8 ...
NCPDP donates a $1 million restricted endowment to the NCPDP Foundation, reinforcing its commitment to advancing healthcare through standards-based information technology and long-term research ...